Pamela Tenaerts

Clinical Trials Transformation Initiative develops and drives adoption of practices that will increase the quality and efficiency of clinical trials. It members include representatives of government agencies, industry representatives, patient advocacy groups, professional societies, investigator groups, academic institutions, and other interested parties. The company was founded in 2007 and is headquartered in Durham, NC.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD.

Sarasota Memorial Hospital provides healthcare services. It specializes in heart, vascular, cancer, neuroscience, outpatient services, rehabilitative care and long-term care among its many programs. The company was founded in 1925 and is headquartered in Sarasota, FL.